Zhang B, Liu H, Shi C, Gao Z, et al. Safety and efficacy of multi-target TKI combined with nivolumab in check-point inhibitor-refractory patients with advanced NSCLC: a prospective, single-arm, two-stage study. BMC Cancer 2024;24:715.
PMID: 38862908